-
2015
Company Description
MirImmune is a biopharmaceutical company focused on the development of new and improved immunotherapies for cancer.
MirImmune is a biopharmaceutical company focused on the development of new and improved immunotherapies for cancer. Aiming to achieve long-term survival of cancer patients, MirImmune combine two leading approaches to cancer treatment: immune checkpoint inhibition and cell-based immunotherapies.
-
Manufacturer:
Science and Engineering -
Formed:
2015 -
Company Website:
-
Company E-mail:
-
Company Address:
Cambridge Biolabs One Kendall Square, Building 200, Suite 2203Cambridge, MAUnited States -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits